These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 21851624)
1. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro. Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells. Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805 [TBL] [Abstract][Full Text] [Related]
5. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression. Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121 [TBL] [Abstract][Full Text] [Related]
7. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221 [TBL] [Abstract][Full Text] [Related]
8. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4. Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127 [TBL] [Abstract][Full Text] [Related]
9. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
10. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1. Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214 [TBL] [Abstract][Full Text] [Related]
12. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression. Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045 [TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2. Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640 [TBL] [Abstract][Full Text] [Related]
14. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666 [TBL] [Abstract][Full Text] [Related]
15. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Godlewski J; Nowicki MO; Bronisz A; Williams S; Otsuki A; Nuovo G; Raychaudhury A; Newton HB; Chiocca EA; Lawler S Cancer Res; 2008 Nov; 68(22):9125-30. PubMed ID: 19010882 [TBL] [Abstract][Full Text] [Related]
16. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Liu W; Zhang B; Xu N; Wang MJ; Liu Q Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990 [TBL] [Abstract][Full Text] [Related]
17. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis. Zheng X; Liu M; Song Y; Feng C Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671 [TBL] [Abstract][Full Text] [Related]
20. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]